SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID19
- Sponsor
- Instituto Costarricense de Investigaciones Clínicas ICIC
- Locations
- 1
- Primary Endpoint
- Presence of disease
- Status
- Withdrawn
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.
Detailed Description
BioSafety Technologies has developed a rapid detection test to clear people of COVID-19. A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel. The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.
Investigators
Dr. Guillermo Rodríguez Gómez
Founder
Instituto Costarricense de Investigaciones Clínicas ICIC
Eligibility Criteria
Inclusion Criteria
- •Older than 7 years odf age Able to provide informed consent Able to take the breath test
Exclusion Criteria
- •Younger than 7 years of age Unable to provide informed consent Unable to take the breath test
Outcomes
Primary Outcomes
Presence of disease
Time Frame: 1 minute
Established diagnosis